Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Depressin Screening and Care Program at Community Health Center

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Hyeon Woo Yim, National Clinical Research Coordination Center, Seoul, Korea
ClinicalTrials.gov Identifier:
NCT01626703
First received: June 20, 2012
Last updated: March 9, 2016
Last verified: March 2016
  Purpose

Depression affect between 5% and 10% of older adults seen in the primary care setting.Late-life depression is often chronic or recurrent and is associated with substantial suffering, functional impairment, and diminished health-related quality of life.Depressed, older primary care patients are frequent users of general medical services and may have poor adherence to medical treatments.They are also at increased risk of death from suicide and medical illnesses. The aim of this study is to examine whether depression screening and health care practitioner feedback are increased depression treatment rate.

Depression screening is provided 60 or more who visited community health care center with a 15-item Geriatric Depression Scale.GDS scores of 10 or more were classified depression positive. Intervention group participants received twice remind calls from primary care nurse.


Condition Intervention
Depression
Screening
Elderly
Other: Reminding call

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Primary Purpose: Screening

Further study details as provided by National Clinical Research Coordination Center, Seoul, Korea:

Primary Outcome Measures:
  • Reuptake rate [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • reduced depressive symptoms [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
    Geriatric Depression Scale Short Form (SGDS)

  • changed perceived heath status [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
    Visual Analogue Scale (VAS)


Enrollment: 86
Study Start Date: June 2012
Study Completion Date: March 2013
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: intervention
remiding call
Other: Reminding call
No Intervention: Control
No intervention

  Eligibility

Ages Eligible for Study:   60 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 60 or more
  • 10 or more in GDS scor

Exclusion Criteria:

  • severe cognitive problem
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01626703

Locations
Korea, Republic of
Chungju community health care center
Chungju, Choongbuk, Korea, Republic of, 123456
Sponsors and Collaborators
National Clinical Research Coordination Center, Seoul, Korea
  More Information

Responsible Party: Hyeon Woo Yim, professor, National Clinical Research Coordination Center, Seoul, Korea
ClinicalTrials.gov Identifier: NCT01626703     History of Changes
Other Study ID Numbers: A102065_2012_2 
Study First Received: June 20, 2012
Last Updated: March 9, 2016
Health Authority: Korea: Ministry of Health and Welfare

ClinicalTrials.gov processed this record on September 26, 2016